Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-202 extension study for central abdominal bulging
NCT02483533Phase 3Terminated
- Sponsor
- Evofem Biosciences, Inc.
- Start
- Jun 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of salmeterol, sponsored by Evofem Biosciences, Inc.. Started Jun 2015; status: terminated.
02
Drugs
salmeterol
Beyond the preview
Go deeper on NCT02483533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483533.